EP 2035002 A1 20090318 - COMBINATION PREPARATIONS COMPRISING SLV308 AND A L-DOPA
Title (en)
COMBINATION PREPARATIONS COMPRISING SLV308 AND A L-DOPA
Title (de)
KOMBINATIONSPRÄPARATE MIT SLV308 UND EINEM L-DOPA
Title (fr)
PRÉPARATIONS COMBINÉES CONTENANT LE SLV308 ET DE LA L-DOPA
Publication
Application
Priority
- EP 2007055955 W 20070615
- US 81405106 P 20060616
- EP 06115583 A 20060616
- EP 07730193 A 20070615
Abstract (en)
[origin: WO2007144421A1] The invention concerns the use of a combination preparation of SLV308 or its N-oxide, or pharmacologically acceptable salts of those compounds (I), (II) and L-DOPA, for simultaneous, separate or sequential use in the treatment of disorders requiring recovery of dopaminergic function, in particular Parkinson's disease and restless leg syndrome.
IPC 8 full level
A61K 31/496 (2006.01); A61K 31/198 (2006.01)
CPC (source: EP KR)
A61K 31/198 (2013.01 - EP KR); A61K 31/496 (2013.01 - EP KR); A61P 25/00 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2007144421A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007144421 A1 20071221; AU 2007259255 A1 20071221; CA 2654719 A1 20071221; EA 015073 B1 20110429; EA 200970021 A1 20090630; EP 2035002 A1 20090318; IL 195532 A0 20090901; JP 2009539941 A 20091119; KR 20090031908 A 20090330; MY 148457 A 20130430; NO 20090164 L 20090114
DOCDB simple family (application)
EP 2007055955 W 20070615; AU 2007259255 A 20070615; CA 2654719 A 20070615; EA 200970021 A 20070615; EP 07730193 A 20070615; IL 19553208 A 20081126; JP 2009514809 A 20070615; KR 20097001024 A 20090116; MY PI20085078 A 20070615; NO 20090164 A 20090112